Tetrahydrofuran → tert-butyl [(1S)-1-methyl-2-(2-naphthyl)-2-oxoethyl]carbamate
Reaction equation
CON(C)[C:4](=[O:15])[C@@H:5]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:13])([CH3:12])[CH3:11])[CH3:6].[CH:17]1[C:26]2[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=2)[CH:20]=[CH:19][C:18]=1[Mg]Br.C1COCC1>>[CH3:6][C@H:5]([NH:7][C:8](=[O:14])[O:9][C:10]([CH3:11])([CH3:12])[CH3:13])[C:4]([C:19]1[CH:18]=[CH:17][C:26]2[C:21](=[CH:22][CH:23]=[CH:24][CH:25]=2)[CH:20]=1)=[O:15]Participants
4
Procedure
The subtitle compound was prepared analogous to the method described in Example 19 (step 19d), starting from (S)-tert-butyl 1-(methoxy(methyl)amino)-1-oxopropan-2-ylcarbamate (1.86 g, 8 mmol) and a freshly prepared 2-Naphthylmagnesiumbromide 1M solution in THF (8 mL, 8 mmol). The obtained material was crystallised from Heptane. Yield 350 mg (14%).
Workup
- customThe obtained material was crystallised from Heptane
Sources & evidence
- ORD record
- ord-2d50303be7f34203ab1d9a22122f95de
- Source dataset
- uspto-grants-2012_03
- Patent number
- US08143290B2
Reaction notes
Loading…